Clinical Trial

The Effects of Adjunctive Therapy With Vaginal Tablets Lactobacillus Acidophilus and a Low Dose Estriol (Gynoflor®) to Prolong Pregnancy Time in Preterm Labor, A Randomized Controlled Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The study aim to study The Adjunctive therapy with vaginal tablets containing Lactobacillus acidophilus KS400 and low-dose Estriol (Gynoflor®) in addition to standard tocolytic treatment administered once daily for 6 days starting the same day as tocolytic therapy, in pregnant women diagnosed with preterm labor at gestational age 24-33 weeks .Primary Outcome is the rate of pregnancy prolongation beyond 7 days after initiation of tocolytic therapy.
Trial Details
NCT Number NCT07344064
Lead Sponsor Queen Savang Vadhana Memorial Hospital, Thailand
Conditions Threaten Preterm, Prethrem Labour, Bacterial Vaginitis
Enrollment 80 participants
Start Date 2026-02
Primary Completion 2026-07 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-15